We are providing preclinical in vivo and in vitro models with focus on autoimmunity and inflammatory conditions. We offer customized, high quality services spanning all aspects of the preclinical phase of the project including Mechanism of Action (MoA) evaluation, ex vivo ranking, Pharmacokinetic (PK) investigation, biomarker identification, in vivo efficacy and biomarker analyses.
By using Redoxis as your service provider you will get:
- High quality studies
- Dedicated personnel with expertise in the field and many years of experience designing studies and interpreting data.
- A committed contact person responsible for your study facilitating communication.
- Flexibility in study design and agility to reduce lead time from decision to execution
Use of animals for experimental and scientific purposes - Statement
All experiments performed by Redoxis follow the national laws of Sweden regarding the protection of animals used for experimental and other scientific purposes. The sufferance of all animals are always kept at a minimum by conducting strictly planned and controlled experiments, corresponding to the concept of the “3Rs” (Replacement, Reduction and Refinement) after Poll et al. (Principles of Human Experimental Technique; Methuen, London, UK, 1959). All studies investigations using In Vivo by Redoxis are performed in conformity with the EU directive 2010/63 on the protection of animals used for scientific purposes.